Global Hypodermic Needles Market by Product Type-(Safety Needles, Non-Safety Needles);Application-Drug Delivery-(Chemotherapy, Plastic Surgery, Others) Vaccination, Blood Specimen Collection, End-User-(Hospital, Dermatology Clinics, Other End-Use) By Region and Key Companies - Industry Segment Outlook, Market Assessment, Competition Scenario, Trends and Forecast 2023–2033

Market Overview

The Global Hypodermic Needles Market size is expected to be worth around USD 4.8 Billion by 2033 from USD 2.7 Billion in 2023, growing at a CAGR of 6.0% during the forecast period from 2024 to 2033.

A hypodermic needle is of hollow shape which is attached with a syringe and typically used to inject drug or substances into the body or extract fluids from body. A hypodermic needle offers rapid delivery of liquids into body. They are also used to take liquid samples from the body, such as blood from a radial artery puncture or vein, etc. They are commercially available in various types and sizes, such as thin wall needles, sterile hypodermic needles, pen needles, insulin needles and winged needles. Hypodermic Needle are commercially available in soft or rigid pack with polypropylene or aluminum hubs.

Growing prevalence of blood-borne diseases such as Hepatitis C (HCV), Hepatitis B (HBV), and Human Immunodeficiency Virus (HIV), etc. is one of the crucial factors which is anticipated to bolster the growth of the global hypodermic needles market. These diseases can spread through contamination by blood and other body fluids. These viruses can enter into blood in the form of microorganisms, such as parasites and bacteria, and non-living infectious agents such as viruses. Sharing a needle or syringe to inject any substance might upsurge the risk of diseases. Henceforth, the demand for a single-use hypodermic needle owing to less pain and less vein damage is growing at a higher pace.
*Actual Numbers Might Vary In The Final Report

Key Takeaways

• Market Size & Growth: Hypodermic Needles Market size is expected to be worth around USD 4.8 Billion by 2033 from USD 2.7 Billion in 2023, growing at a CAGR of 6.0%.
• Product Type Analysis: safety needles held the 54.6% market share in 2023.
• Application Analysis: Drug delivery dominated the market in 2023 with 47% revenue share.
• End-user Analysis: Hospital segment accounted 51% market share in 2023.
• Regional Analysis: North America dominating 38% share in 2023 and accounting for USD 1.2 Billion in sales revenue.
• Rising Demand for Self-Administration Devices: One trend evident in the Hypodermic Needles Market is the increasing interest for self-administration devices.
• Regulatory Scrutiny and Safety Concerns: The market is subject to intense governmental oversight, particularly regarding needle safety practices. Stringent regulations designed to protect healthcare professionals and patients may present market players with unique challenges.
• Technological Advances to Promote Needle Safety: One significant trend involves continuous technological improvements for needle safety.

Product Type Analysis

Based product types, there are two kinds of needles: safety and non-safety needles. As of 2023, safety needles held the 54.6% market share and saw the greatest compound annual growth over their projected timeframe. Safety syringes stand out from their counterparts by virtue of their built-in safety mechanism, designed to minimize needlestick injuries.

Many countries have implemented regulations mandating their use and discouraging reuse of needles. Safety syringes have seen rapid adoption, even surpassing their popularity among traditional ones. Notable players in the safety needle market include BD and Cardinal Health; BD offers both active and passive needle-based safety systems while Cardinal Health’s Monoject and Magellan brands specialize in safety needles.

Non-safety needles, being more cost-effective, still offer safe injections when used correctly. Their popularity can be attributed to widespread vaccination programs as well as rising birth rates in developing nations driving a surge in demand for vaccines. BD’s general-use hypodermic needles feature regular bevel and wall angles to provide smooth vein entry with minimal drag.

By Application Analysis

Based on application, the global hypodermic needles market can be divided into drug delivery, vaccination and blood specimen collection segments. Drug delivery dominated the market in 2023 with 47% revenue share and is projected to experience the highest compound annual growth during its forecast period. Injectable drug delivery systems provide a large surface area for systematic absorption.

Their growth can adapt to increasing prevalence of chronic diseases as well as rising demand for vaccines, insulin, human growth hormone, modern medicines and biosimilar products – particularly low-cost hypodermic needles – among others. Biosimilar clinical trials are being conducted across many companies at present which may offer lucrative opportunities over time.

In 2023, vaccination was the second-largest market segment with significant demand and growth potential. Every year vaccination saves millions of lives worldwide while governments around the globe invest heavily to alleviate global disease burden using vaccines as first line defence against epidemics that might lead to healthcare emergencies. Many global organizations collaborated with regional governments in purchasing large quantities of syringes and needles for vaccination rollout programs – fuelling further segment growth due to growing epidemic potential, an emphasis on therapeutic vaccines, and emerging markets.

By End-user Analysis

Hospitals are major consumers of hypodermic needles, In 2023, hospital segment accounted 51% market share, hospital employing them for various medical procedures like drug administrations, vaccinations and blood specimen collection. Hospitals’ demand for hypodermic needles is closely connected with their wide array of healthcare activities performed within these healthcare institutions; high-quality hypodermic needles are especially essential given their critical environment where precise procedures must take place in a sterile environment.

Hospitals play an essential part of healthcare infrastructure, serving as hubs for patient care, treatment and medical interventions. Hospitals also utilize hypodermic needles extensively in many medical departments – from emergency care and surgery to routine vaccinations and diagnostic tests. Therefore, the hospital end user segment significantly impacts overall growth dynamics within the Hypodermic Needles Market.

One of the smallest pieces of medical equipment used in numerous hospitals, pharmacies, and clinics is a hypodermic needle. Hypodermic line of needles is sharp, tri-beveled stainless steel needles with a non-coring design. These needles are completely designed for penetrating through skin and blood. The patient will feel less pain and less damage is caused to vessel or vein. They might be used to take liquid samples from the body. Large-bore hypodermic intervention is specifically useful in treating catastrophic blood loss or shock. Hypodermic needles are highly utilized owing to the low risk of infection or contamination.

History

The hypodermic needle was invented by Mr. Charles Gabriel Pravaz – a Frenchman and Mr. Alexander Wood – an Englishman in 1853. After that, these hypodermic needles have been extensively used in the medical and healthcare sector.

needles have several features such as single-handed activation, safety mechanism, double-locking mechanism, lower-angle injections, easy positioned safety arm, compatible with all standard luer lock and luer slip-tip syringes, and has ISO color code identification. Hypodermic needles of particular sizes are chosen to administer insulin, drugs, vaccinations and other substances or extracting fluids and tissues.

*Actual Numbers Might Vary In The Final Report

Market Segmentation

Product Type

• Safety Needles
• Non-Safety Needles

Application

Drug Delivery

• Chemotherapy
• Plastic Surgery
• Others

Vaccination

Blood Specimen Collection

End-User

• Hospital
• Dermatology Clinics
• Other End-Use

Driver

Increase in Chronic Disease Prevalence

Hypodermic Needles Market growth has been driven forward by an escalating prevalence of chronic diseases worldwide, particularly diabetes, cardiovascular conditions, and autoimmune disorders. Such illnesses require consistent medication administration via hypodermic needles as part of drug delivery systems for effective management. As diabetes, cardiovascular illnesses, autoimmune disorders require close treatment management by patients as a part of managing them using injections, insulin shots or other forms of treatment administered using hypodermic needles has significantly increased worldwide due to this global surge of chronic illnesses; its rising demand acts as an accelerator driving market growth forward.

An increasingly ageing global population contributes to an increased incidence of chronic conditions, fueling demand for hypodermic needles. With individuals becoming more at risk of chronic illnesses as they get older, this demographic shift amplifies market momentum by creating efficient drug delivery systems for chronic illnesses that patients are likely to require more of. Chronic diseases have become one of the key driving forces in shaping this market space for hypodermic needles worldwide.

Trend

Technological Advancements in Needle Safety

Hypodermic Needles Market participants should look out for the continual advancement of needle safety technologies. With increasing emphasis on healthcare worker and patient wellness, there has been an impressive move toward the incorporation of advanced safety features into hypodermic needle designs to protect healthcare worker wellbeing and patient wellbeing. Needlestick injuries present significant risk in healthcare environments; due to this fact safety-engineered devices like retractable needles with shielding mechanisms are now widely utilized within healthcare settings and needletick injuries have decreased drastically over time – becoming less of an issue than before!

This trend is driven by an emphasis on both improving patient comfort and protecting healthcare professionals from accidental needlestick injuries. Manufacturers in the market have invested in research and development efforts aimed at creating needles with advanced safety features without compromising efficacy, making their use an indicator of an industry commitment to minimizing risks associated with needle use – thus becoming an industry trend in itself.

Restraint

Systems for Needlestick Injuries and Regulations (RNBIRs)

Hypodermic Needles Market competitors must contend with concerns surrounding needlestick injuries and stringent regulations governing needle usage. Needlestick injuries pose an immense threat to healthcare professionals by exposing them to bloodborne pathogens and infections; consequently, this fear has raised awareness regarding safety practices for needle usage.

Stringent regulations, while essential in upholding safety standards, present market players with many challenges. Compliance often necessitates substantial investments into developing safety engineered needles with rigorous quality standards adherence; as well as increased production costs which impact profit margins of manufacturers. Healthcare facilities may incur financial strain from adopting safety measures or training programs intended to prevent needlestick injuries – both factors which impede dynamics of the Hypodermic Needles Market significantly.

Opportunity

Increase in Demand for Self-Administrator Devices

Hypodermic Needles Market opportunities arise from increasing consumer interest for self-administration devices. As more individuals take an active part in managing their healthcare, more patients prefer self-dosing medications at home for chronic disease management – this trend becoming particularly evident as more convenient means are sought to administer treatments prescribed.

Hypodermic needles designed for self-administration devices provide manufacturers with an attractive market growth opportunity. Manufacturers are focused on designing patient-centric technologies to meet this growing need; wearable drug delivery devices like autoinjectors and pen injectors represent another valuable opportunity. Wearable devices allow patients to administer their medications more reliably, leading to improved treatment adherence and overall patient satisfaction.

Regional Analysis

North America dominating 38% share in 2023 and accounting for USD 1.2 Billion in sales revenue. This significant market presence can be attributed to multiple factors, including rising blood donations rates, infection cases increasing exponentially, presence of advanced infrastructure within hospitals and clinical laboratories, increase in surgical procedures performed daily, as well as significant innovations by major market players.

United States. An increase in elderly population, more susceptible to various disorders and the increase in cancer, diabetes, chronic pain and gastrointestinal diseases has the potential to significantly expand the hypodermic needle market. Aging demographics are contributing to an increased need for medical interventions which require hypodermic needles for medical procedures.

*Actual Numbers Might Vary In The Final Report

Key Regions

North America

• The US
• Canada
• Mexico

Western Europe

• Germany
• France
• The UK
• Spain
• Italy
• Portugal
• Ireland
• Austria
• Switzerland
• Benelux
• Nordic
• Rest of Western Europe

Eastern Europe

• Russia
• Poland
• The Czech Republic
• Greece
• Rest of Eastern Europe

APAC

• China
• Japan
• South Korea
• India
• Australia & New Zealand
• Indonesia
• Malaysia
• Philippines
• Singapore
• Thailand
• Vietnam
• Rest of APAC

Latin America

• Brazil
• Colombia
• Chile
• Argentina
• Costa Rica

Rest of Latin America

Middle East & Africa

• Algeria
• Egypt
• Israel
• Kuwait
• Nigeria
• Saudi Arabia
• South Africa
• Turkey
• United Arab Emirates
• Rest of MEA

Key Players Analysis

Hypodermic needles market competitive landscape provides details by competitor. Information included include an overview of the company, financials and revenue potential, market opportunities, investment into research and development the latest initiatives in the market with global reach manufacturing sites and facilities production capacities strength and weaknesses of the company and weaknesses, product launches, product size and breadth, as well as application dominance. The data provided above are only relevant to businesses’ attention to the hypodermic needles.

Кеу Рlауеrѕ

• B. Braun Melsungen AG
• Medline Industries Inc
• The Smith Group Inc
• Nipro Corporation
• Terumo Medical Corporation
• Becton, Dickinson and Company
• Novo Nordisk
• Medtronic Plc.
• Cardinal Health
• Cadence Science
• Other Key Players

Recent Developments

• January 2023 – New safety needle designs with enhanced needle shielding mechanisms, smart needle technology for real-time tracking and usage monitoring, as well as FDA approval of an innovative needleless injection system for insulin delivery will have been created and introduced.
• April 2023 – Research findings highlighting the efficacy of needle coatings in reducing injection pain; an expansion in minimally invasive procedures using specialty hypodermic needles; and increasing emphasis on sustainable manufacturing practices within the hypodermic needle industry are among the many topics being presented for discussion at this event.
• May 2023 – Regulation approval of a new needle design with improved sharpness and penetration efficiency; development of needle-based drug delivery systems for targeted cancer therapy; increasing adoption of needleless injection systems for pediatric vaccinations.
• August 2023 – Needle-based drug delivery systems designed for personalized medicine applications, integration of needle tracking technology into hospital asset management systems and increased adoption of needleless injection systems for vaccine administration are among the many technologies under development and deployment in developing nations.

Report Scope